nicholas j valeriani  rti surgical inc search rti surgical everything products news pages products  news  pages  products no search results for document script spokewidgetjsscript div classspokewidget datahostwwwspokecom datatypeperson dataidececba datawidth dataheight datascrollno dataframebordernonediv div stylefontsize pta hrefhttpwwwspokecompeoplenicholasvalerianiececbanicholas valeriania widget provided by a hrefhttpwwwspokecomspokeadiv public records our partner can help you find public records for nicholas more on some of spokes content providers become a spoke content provider learn more ﻿ nic inc nasdaqegov upgraded to outperform at imperial capital  chaffey breeze daily ratings  news for nic inc complete the form below to receive the latest headlines and analysts recommendationsfor nic inc with our free daily email newsletter follow chaffeybreeze recent posts nic inc nasdaqegov upgraded to outperform at imperial capital sandvine co svc given new c price target at royal bank of canada gea group aktiengesellschaft ga given a € price target at independent research gmbh barclays plc reiterates  price target for commerce bancshares inc nasdaqcbsh therapeuticsmd inc nasdaqtxmd rating reiterated by cowen and company hess midstream partners lp nasdaqhesm upgraded to “buy” at zacks investment research jefferies group llc reiterates “buy” rating for masco corporation nysemas barclays plc reiterates “equal weight” rating for bruker corporation nasdaqbrkr jcdecaux sa dec given a € price target at hsbc holdings plc axt inc nasdaqaxti set to announce quarterly earnings on wednesday aci worldwide inc aciw scheduled to post quarterly earnings on wednesday qualcomm incorporated nasdaqqcom shares sold by weatherly asset management l p great west life assurance co can lowers stake in alnylam pharmaceuticals inc nasdaqalny costco wholesale corporation nasdaqcost stock rating reaffirmed by oppenheimer holdings inc state board of administration of florida retirement system continues to hold stake in lydall inc nyseldl first trust advisors lp boosts stake in tier reit inc otcmktstier kinross gold corporation nysekgc rating lowered to sell at bidaskclub first trust advisors lp has  million position in kaman corporation nysekamn state board of administration of florida retirement system continues to hold position in everbank financial corp nyseever first trust advisors lp boosts stake in first foundation inc nasdaqffwm nic inc nasdaqegov upgraded to outperform at imperial capital posted by charlotte bryant on jul th   no comments imperial capital upgraded shares of nic inc nasdaqegov from an inline rating to an outperform rating in a report released on monday morning imperial capital currently has  target price on the software maker’s stock several other equities research analysts also recently issued reports on the company bidaskclub downgraded nic from a sell rating to a strong sell rating in a report on friday june th zacks investment research downgraded nic from a buy rating to a hold rating in a report on monday july rd finally da davidson started coverage on nic in a report on wednesday june th they issued a neutral rating and a  price target for the company two research analysts have rated the stock with a sell rating four have issued a hold rating and three have given a buy rating to the company’s stock nic presently has an average rating of hold and a consensus target price of  get nic inc alerts shares of nic nasdaqegov opened at  on monday the firm’s day moving average price is  and its day moving average price is  nic has a  month low of  and a  month high of  the firm has a market capitalization of  billion a pricetoearnings ratio of  and a beta of  nic nasdaqegov last announced its quarterly earnings results on monday may st the software maker reported  earnings per share eps for the quarter topping the consensus estimate of  by  nic had a return on equity of  and a net margin of  the company had revenue of  million during the quarter compared to the consensus estimate of  million during the same period in the prior year the company earned  earnings per share the company’s revenue for the quarter was up  compared to the same quarter last year on average equities analysts anticipate that nic will post  earnings per share for the current year copyright violation warning “nic inc nasdaqegov upgraded to outperform at imperial capital” was first posted by chaffey breeze and is owned by of chaffey breeze if you are reading this news story on another website it was illegally copied and reposted in violation of international copyright  trademark laws the original version of this news story can be read at httpswwwchaffeybreezecomnicincnasdaqegovupgradedtooutperformatimperialcapitalhtml the company also recently disclosed a quarterly dividend which was paid on tuesday june th investors of record on tuesday june th were issued a dividend of  per share the exdividend date of this dividend was friday june nd this represents a  dividend on an annualized basis and a dividend yield of  nic’s payout ratio is presently  in related news coo robert w knapp sold  shares of the stock in a transaction dated monday may nd the stock was sold at an average price of  for a total transaction of  following the completion of the transaction the chief operating officer now directly owns  shares in the company valued at  the transaction was disclosed in a filing with the sec which can be accessed through this link  of the stock is currently owned by company insiders hedge funds and other institutional investors have recently bought and sold shares of the company ameritas investment partners inc purchased a new position in nic during the first quarter worth about  sg americas securities llc increased its position in nic by  in the first quarter sg americas securities llc now owns  shares of the software maker’s stock worth  after buying an additional  shares during the last quarter state of alaska department of revenue increased its position in nic by  in the first quarter state of alaska department of revenue now owns  shares of the software maker’s stock worth  after buying an additional  shares during the last quarter advisors asset management inc increased its position in nic by  in the first quarter advisors asset management inc now owns  shares of the software maker’s stock worth  after buying an additional  shares during the last quarter finally envestnet asset management inc increased its position in nic by  in the fourth quarter envestnet asset management inc now owns  shares of the software maker’s stock worth  after buying an additional  shares during the last quarter institutional investors and hedge funds own  of the company’s stock nic company profile nic inc is a provider of digital government services that help governments use technology to provide services to businesses and citizens the company operates through outsourced portals segment the company offers its services through two channels primary outsourced portal businesses and software and services businesses receive news  ratings for nic inc daily  enter your email address below to receive a concise daily summary of the latest news and analysts ratings for nic inc and related companies with marketbeatcoms free daily email newsletter latest news leave a reply click here to cancel reply name required mail will not be published required website nicholas valeriani appointed to roka bioscience’s board of directors nicholas valeriani appointed to roka biosciences board of directors aug    et from roka bioscience inc roka bioscience     facebook twitter pinterest roka bioscience warren nj aug   prnewswire  roka bioscience inc nasdaq roka a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens today announced that nicholas j valeriani has been appointed to its board of directors  since  mr valeriani  has been the chief executive officer of the gary and mary west health institute  mr valeriani has announced plans to retire from the organizations chief executive position effective september   however he will remain on the institutes board of directors and will join the gary and mary west health policy centers board   prior to joining west health mr valeriani spent  years at johnson  johnson and served as a member of its executive committee  we are pleased to add nicks talents and deep experience to our board said paul thomas rokas ceo and president mr valeriani brings a unique perspective to our board through his vast diagnostics expertise and track record of driving achievement of strategic and operating objectives i and the other members of the roka board look forward to working with nick as we continue to make progress toward our key initiatives and position roka for accelerated longterm growth currently mr valeriani serves on the boards of directors of robert wood johnson university hospital edwards lifesciences corporation and the center for medical interoperability  mr valeriani has a masters degree in business administration from rutgers university graduate school of management and a bachelors degree in industrial engineering from rutgers university college of engineering about roka bioscience roka bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market our atlas detection assays incorporate our advanced molecular technologies and are performed on our samplein resultout atlas system that automates all aspects of molecular diagnostic testing on a single integrated platform the atlas system and detection assays are designed to provide our customers with accurate and rapid test results with reduced labor costs and improved laboratory efficiencies  for more information visit httprokabiocom forward looking statements this press release contains forwardlooking statements within the meaning of section a of the securities act of  and section e of the securities exchange act of  and the private securities litigation reform act as amended the exchange act these forwardlooking statements are based on current expectations estimates forecasts and projections about the industry and markets in which we operate and managements current beliefs and assumptions any statements contained herein including without limitation statements to the effect that we believe expect anticipate plan and similar expressions that are not statements of historical fact should be considered forwardlooking statements  these statements relate to future events or our financial performance and involve known and unknown risks uncertainties and other factors that could cause our actual results levels of activity performance or achievement to differ materially from those expressed or implied by these forward looking statements there are a number of important factors that could cause actual results to differ materially from those indicated by such forwardlooking statements such factors include those set forth in the companys filings with the securities and exchange commission we expressly disclaim any obligation to update any forwardlooking statements except as may be required by law  given these uncertainties you should not place undue reliance on these forwardlooking statements these forwardlooking statements represent our estimates and assumptions only as of the date of this press release and except as required by law we undertake no obligation to update or review publicly any forwardlooking statements whether as a result of new information future events or otherwise after the date of this press release investor contact   roka bioscience inc  irrokabiocom  rokabio   logo  httpphotosprnewswirecomprnhlogo source roka bioscience inc related links httpwwwrokabiocom view table fullscreen view table fullscreen journalists and bloggers the news you need when you need it join pr newswire for journalists to access all of the free services designated to make your job easier in need of subject matter experts for your story submit a free profnet request and find the sources you need learn more aug    et preview roka bioscience reports second quarter  financial results aug    et preview roka bioscience to report second quarter  financial results on august   my news release contains wide tables view fullscreen read more jul    et roka bioscience announces aoac certification for hour sample jul    et roka bioscience inc announces comarketing and supply agreement jul    et roka bioscience to present at the international association of looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search board of directors search contact customerlogin ☰ technology overview ribosomal rna targeting target capture transcriptionmediated amplification hybridization protection assay products overview atlas® system atlas e coli oh eg detection assay atlas stec eg combo detection assay atlas listeria lsp detection assay atlas listeria monocytogenes lmg detection assay atlas salmonella sen detection assay solutions beef dairy pet food poultry join the fda for a day program produce ready to eat foods spices and ingredients environmental testing solutions support frequently asked questions overview support materials technical support customer service ask for atlas investors welcome corporate governance executive team board of directors committee charters news releases financials and filings events and presentations investor faqs investor alerts about company overview food safety industry company history iso   board of directors executive team partners careers meetings  events blog board of directors welcome corporate governance executive team board of directors committee charters news releases financials and filings events and presentations investor faqs investor alerts nicholas j valeriani has served as a member of our board of directors since august  mr valeriani was the chief executive officer of the gary and mary west health institute an independent nonprofit medical research organization that works to create new more effective ways of delivering care at lower costs from  through september  since september  mr valeriani has served on the gary and mary west health institute’s board of directors and the gary and mary west health policy center’s board prior to joining west health in  mr valeriani spent  years at johnson  johnson nyse jnj and served as a member of its executive committee currently mr valeriani serves on the boards of directors of rti surgical inc nasdaq rtix a global surgical implant company and edwards lifesciences corporation nyse ew mr valeriani has a masters degree in business administration from rutgers university graduate school of management and a bachelors degree in industrial engineering from rutgers university college of engineering we believe that mr valerianis management experience including his experience as an executive at johnson  johnson and his experience as a director of other publiclytraded companies and his experience in the financial sector qualifies him to serve as a member of our board of directors price datanasdaqroka dymomoyryr privacy policy site map terms of use  trademarks roka molecular technology is licensed from hologic inc  copyright  roka bioscience all rights reserved